Prospective Study of White Blood Cells

Recruiting

• Conditions: Autoimmune Diseases; Inflammation; Rejection; Transplant, Liver
• Interventions: Other: White blood cell and blood collection

• Registration Number: NCT04838171
• Lead Sponsor: Quell Therapeutics Limited

Brief Summary

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-24
• Study First Submitted: 2021-04-01
• Study First Submitted QC: 2021-04-06
• Study First Posted: 2021-04-08
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-22
• Last Update Posted: 2024-11-26
• Primary Completion: 2024-12
• Study Completion: 2024-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Specimen collection to support development of engineering Treg	White blood cell and blood collection	-

Primary Outcome Measures

Name	Time	Method
WBC characterisation to support the development of engineered regulatory T cells.	5 years	number, type and function of white blood cells in healthy controls and in patients

Trial Locations

Locations (1)

Quell Investigator Site 01; 🇬🇧 London, United Kingdom